News
Although the market has been uncomfortably choppy in recent sessions, this is also the time for contrarians to pick up hot ...
Viking Therapeutics (VKTX) stock fell after Phase 2 trial results for obesity drug VK2735, drawing various views on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results